A Multicenter, Prospective, Randomized, Open-label Study to Compare the Efficacy, Safety, and Tolerability of BOTOX® and Topiramate for Headache Prophylaxis in Adults With Chronic Migraine
Phase of Trial: Phase IV
Latest Information Update: 29 Nov 2017
At a glance
- Drugs Botulinum toxin A (Primary) ; Topiramate
- Indications Migraine
- Focus Therapeutic Use
- Acronyms FORWARD
- Sponsors Allergan
- 29 Nov 2017 According to an Allergan media release, data from the study will be presented at the 11th European Headache Federation (EHF) Congress 2017.
- 11 Oct 2017 Status changed from active, no longer recruiting to completed.
- 06 Sep 2017 According to an Allergan media release, data from the study will be presented at the upcoming 18th Congress of the International Headache Society (IHC2017).